A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma.

Edward Pan, Daohai Yu, Binglin Yue, Lisa Potthast, Sajeel Chowdhary, Pamela Smith, Marc Chamberlain

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of neuro-oncology
Volume110
DOIs
StatePublished - Jul 26 2012
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gastroenterology
  • Surgery
  • Internal Medicine

Cite this